184 related articles for article (PubMed ID: 20686609)
1. Comparative functional genomics analysis of NNK tobacco-carcinogen induced lung adenocarcinoma development in Gprc5a-knockout mice.
Fujimoto J; Kadara H; Men T; van Pelt C; Lotan D; Lotan R
PLoS One; 2010 Jul; 5(7):e11847. PubMed ID: 20686609
[TBL] [Abstract][Full Text] [Related]
2. Development of Kras mutant lung adenocarcinoma in mice with knockout of the airway lineage-specific gene Gprc5a.
Fujimoto J; Nunomura-Nakamura S; Liu Y; Lang W; McDowell T; Jakubek Y; Ezzeddine D; Kapere Ochieng J; Petersen J; Davies G; Fukuoka J; Wistuba II; Ehli E; Fowler J; Scheet P; Kadara H
Int J Cancer; 2017 Oct; 141(8):1589-1599. PubMed ID: 28653505
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of lung tumorigenesis in a Gprc5a Knockout mouse by chronic extrinsic airway inflammation.
Barta P; Van Pelt C; Men T; Dickey BF; Lotan R; Moghaddam SJ
Mol Cancer; 2012 Jan; 11():4. PubMed ID: 22239913
[TBL] [Abstract][Full Text] [Related]
4. A Gprc5a tumor suppressor loss of expression signature is conserved, prevalent, and associated with survival in human lung adenocarcinomas.
Kadara H; Fujimoto J; Men T; Ye X; Lotan D; Lee JS; Lotan R
Neoplasia; 2010 Jun; 12(6):499-505. PubMed ID: 20563252
[TBL] [Abstract][Full Text] [Related]
5. Development of ferret as a human lung cancer model by injecting 4-(Nmethyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
Aizawa K; Liu C; Veeramachaneni S; Hu KQ; Smith DE; Wang XD
Lung Cancer; 2013 Dec; 82(3):390-6. PubMed ID: 24396883
[TBL] [Abstract][Full Text] [Related]
6. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
[TBL] [Abstract][Full Text] [Related]
7. Genome-Wide Gene Expression Changes in the Normal-Appearing Airway during the Evolution of Smoking-Associated Lung Adenocarcinoma.
Kantrowitz J; Sinjab A; Xu L; McDowell TL; Sivakumar S; Lang W; Nunomura-Nakamura S; Fukuoka J; Nemer G; Darwiche N; Chami H; Tfayli A; Wistuba II; Scheet P; Fujimoto J; Spira AE; Kadara H
Cancer Prev Res (Phila); 2018 Apr; 11(4):237-248. PubMed ID: 29382653
[TBL] [Abstract][Full Text] [Related]
8. Array CGH analysis reveals chromosomal aberrations in mouse lung adenocarcinomas induced by the human lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Herzog CR; Desai D; Amin S
Biochem Biophys Res Commun; 2006 Mar; 341(3):856-63. PubMed ID: 16455056
[TBL] [Abstract][Full Text] [Related]
9. Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces cell proliferation in normal human bronchial epithelial cells through NFkappaB activation and cyclin D1 up-regulation.
Ho YS; Chen CH; Wang YJ; Pestell RG; Albanese C; Chen RJ; Chang MC; Jeng JH; Lin SY; Liang YC; Tseng H; Lee WS; Lin JK; Chu JS; Chen LC; Lee CH; Tso WL; Lai YC; Wu CH
Toxicol Appl Pharmacol; 2005 Jun; 205(2):133-48. PubMed ID: 15893541
[TBL] [Abstract][Full Text] [Related]
10. Targeted disruption of the galectin-3 gene results in decreased susceptibility to NNK-induced lung tumorigenesis: an oligonucleotide microarray study.
Abdel-Aziz HO; Murai Y; Takasaki I; Tabuchi Y; Zheng HC; Nomoto K; Takahashi H; Tsuneyama K; Kato I; Hsu DK; Liu FT; Hiraga K; Takano Y
J Cancer Res Clin Oncol; 2008 Jul; 134(7):777-88. PubMed ID: 18204863
[TBL] [Abstract][Full Text] [Related]
11. Identification of cytochrome P450 enzymes critical for lung tumorigenesis by the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK): insights from a novel Cyp2abfgs-null mouse.
Li L; Megaraj V; Wei Y; Ding X
Carcinogenesis; 2014 Nov; 35(11):2584-91. PubMed ID: 25173884
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of microRNAs in early-stage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Kalscheuer S; Zhang X; Zeng Y; Upadhyaya P
Carcinogenesis; 2008 Dec; 29(12):2394-9. PubMed ID: 18780894
[TBL] [Abstract][Full Text] [Related]
13. K-ras mutations in lung tumors from A/J and A/J x TSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate.
Matzinger SA; Crist KA; Stoner GD; Anderson MW; Pereira MA; Steele VE; Kelloff GJ; Lubet RA; You M
Carcinogenesis; 1995 Oct; 16(10):2487-92. PubMed ID: 7586156
[TBL] [Abstract][Full Text] [Related]
14. Induction of Lung Tumors and Mutational Analysis in FVB/N Mice Treated with the Tobacco Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone.
Rothenberger NJ; Stabile LP
Methods Mol Biol; 2020; 2102():149-160. PubMed ID: 31989553
[TBL] [Abstract][Full Text] [Related]
15. Aberrant promoter hypermethylation of the death-associated protein kinase gene is early and frequent in murine lung tumors induced by cigarette smoke and tobacco carcinogens.
Pulling LC; Vuillemenot BR; Hutt JA; Devereux TR; Belinsky SA
Cancer Res; 2004 Jun; 64(11):3844-8. PubMed ID: 15172992
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the transplacental tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice.
Anderson LM; Hecht SS; Dixon DE; Dove LF; Kovatch RM; Amin S; Hoffmann D; Rice JM
Cancer Res; 1989 Jul; 49(14):3770-5. PubMed ID: 2736518
[TBL] [Abstract][Full Text] [Related]
17. Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers and metabolites in the A/J mouse.
Upadhyaya P; Kenney PM; Hochalter JB; Wang M; Hecht SS
Carcinogenesis; 1999 Aug; 20(8):1577-82. PubMed ID: 10426810
[TBL] [Abstract][Full Text] [Related]
18. Early and delayed intervention with rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice.
Patlolla JM; Kopelovich L; Qian L; Zhang Y; Kumar G; Madka V; Mohammed A; Biddick L; Sadeghi M; Lightfoot S; Rao CV
Oncol Rep; 2015 Dec; 34(6):2925-34. PubMed ID: 26397133
[TBL] [Abstract][Full Text] [Related]
19. Expression of cell cycle proteins in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumors.
Sabourin CL; Wang QS; Ralston SL; Evans J; Coate J; Herzog CR; Jones SL; Weghorst CM; Kelloff GJ; Lubet RA; You M; Stoner GD
Exp Lung Res; 1998; 24(4):499-521. PubMed ID: 9659580
[TBL] [Abstract][Full Text] [Related]
20. Synergism between 2,3,7,8-tetrachlorodibenzo-p-dioxin and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone on lung tumor incidence in mice.
Wang YJ; Chang H; Kuo YC; Wang CK; Siao SH; Chang LW; Lin P
J Hazard Mater; 2011 Feb; 186(1):869-75. PubMed ID: 21167638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
